Last reviewed · How we verify
NCT07215884
Dopamine and Sensorimotor Function in Stuttering
Phase 1 trial testing Aripiprazole 10 MG in Stuttering, Adult in 40 participants. Currently enrolling.
30 June 2026
Quick facts
| Lead sponsor | University of California, San Francisco |
|---|---|
| Phase | Phase 1 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 40 |
| Start date | 30 September 2025 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Aripiprazole 10 MG — full drug profile →
- Placebo
Conditions studied
- Stuttering, Adult — all drugs for Stuttering, Adult →
Sponsor
University of California, San Francisco
Who can join
Adults 18 to 65, any sex, with Stuttering, Adult. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07215884
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Aripiprazole 10 MG
Trials testing the same drug.
- NCT05766540 — Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT · Phase 4 · unknown
Other recruiting trials for Stuttering, Adult
Currently open trials in the same condition.
- NCT07389694 — Using Transcranial Magnetic Stimulation to Treat Stuttering · NA · recruiting
- NCT06422442 — Information Processing Biases in Adults Who Stutter · NA · recruiting
- NCT05908123 — Exploring the Nature, Assessment and Treatment of Stuttering · NA · recruiting
Other University of California, San Francisco trials
Trials by the same sponsor.
- NCT05284773 — Screening for Acute Malnutrition · NA · withdrawn
- NCT04634851 — Video Home Visits for Dietary Counselling · NA · not yet recruiting
- NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M · Phase 1, PHASE2 · not yet recruiting
- NCT07534098 — Intervention for Hearing Health Among Native Americans · NA · not yet recruiting
- NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07215884 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
- Last refreshed: 14 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07215884.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing